The Impact of Telelactation Services on Breastfeeding Outcomes

Overview

This project will assess the impact of a novel breastfeeding support intervention ("telelactation"), delivered via video calls on personal devices including mobile phones and tablets. The goal of this intervention is to increase access to International Board Certified Lactation Consultants to improve, and reduce disparities in, breastfeeding rates. By implementing a digital randomized controlled trial that recruits participants through a popular pregnancy tracker mobile phone application, this mixed methods study will recruit a national sample of 1800-2400 individuals (depending on rate of attrition) during their third trimester of pregnancy to 1) provide evidence on the effectiveness of a widely available, yet understudied, service and 2) leverage technology to promote one of the most widely recommended health behaviors to improve children's health and to reduce disparities in key maternal and child health outcomes.

Full Title of Study: “The Impact of Telelactation Services on Breastfeeding Outcomes: Digital Tele-MILC Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: Single (Care Provider)
  • Study Primary Completion Date: July 10, 2024

Detailed Description

This study is a pragmatic, parallel design randomized controlled trial that will generate evidence on the impact of telelactation on breastfeeding duration and exclusivity and explore differences in effectiveness by race/ethnicity. The study is mixed methods, and uses a sequential explanatory design in which qualitative interviews are used to explain and contextualize findings from the quantitative outcomes analysis. We will recruit primiparous, pregnant individuals age > 18 who intend to breastfeed and live in states most underserved by IBCLCs. Recruitment will occur via Ovia, a pregnancy tracker mobile phone application (app) used by one million pregnant individuals in the U.S. annually. Participants will be randomized to: 1) on-demand telelactation video calls on personal devices or 2) ebook on infant care/usual care. Breastfeeding outcomes will be captured via surveys and interviews and compared across racial and ethnic groups. This study will track participants for eight months (including six months postpartum), generating 1) quantitative data on the impact of telelactation and differences in effectiveness across racial and ethnic minority groups; and 2) rich qualitative data on the experiences of different subgroups of parents with the intervention, including barriers to use, satisfaction, and strengths and limitations of this delivery model.

Interventions

  • Behavioral: Telelactation support
    • Participants will get unlimited access (through 24 weeks postpartum) to video calls with lactation consultants who are available 24/7. Participants can use the service as demanded.

Arms, Groups and Cohorts

  • Experimental: Telelactation support
    • Participants in the experimental group will receive unlimited, free telelactation visits with lactation consultants (IBCLCs) as demanded up to 24 weeks post-partum. Services will be available through mobile phone app.
  • No Intervention: ebook
    • Participants in the control arm will receive care as usual. They will also receive a ebook with content on infant care.

Clinical Trial Outcome Measures

Primary Measures

  • Breastfeeding duration 1
    • Time Frame: 6 months postpartum
    • Any breastfeeding (yes/no) at 6 months
  • Breastfeeding duration 2
    • Time Frame: 6 months post-partum
    • Time to cessation of breastfeeding in months (as measured by reported age of infant when completely stopped receiving breastmilk)
  • Breastfeeding exclusivity
    • Time Frame: 6 months postpartum
    • No formula use in the prior 24 hours (yes/no) at 6 months

Secondary Measures

  • Breastfeeding satisfaction
    • Time Frame: 6 months postpartum
    • Breastfeeding satisfaction (self-reported via questionnaire at 6 months postpartum). Score on five-item maternal/infant breastfeeding satisfaction scale (which is a subscale of the H&H lactation scale).
  • Experiences with telelactation
    • Time Frame: 8 weeks postpartum
    • Qualitative data from semi-structured interviews on experiences with telelactation

Participating in This Clinical Trial

Inclusion Criteria

  • ≥ 18 years of age – pregnant with first child – intend to attempt breastfeeding – residing in a state underserved by IBCLCs Exclusion Criteria:

  • non-singleton pregnancy – advised by healthcare provider not to breastfeed for a medical reason (e.g., HIV+ status, chemotherapy planned) – in police custody or incarcerated – infant to be separated from birthing parent (e.g., given up for adoption, military deployment)

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • RAND
  • Collaborator
    • University of Pittsburgh
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.